Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

12 results
Display

A Case of Miillerian Adenosarcoma of the Uterus with Squamous Cell Carcinoma of the Uterine Cervix

Shin JS, Lee NW, Kim HJ, Kim YS, Kim CH

  • KMID: 2083742
  • Korean J Gynecol Oncol Colposc.
  • 1999 Jun;10(2):200-204.
Mullerian adenosarcoma is an uncommon variant of MQllerian mixed tumors of the uterus and a mixed, biphasic neoplasia in which the mesenchymal component is malignant and the epithelial component is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Cellular Schwannoma of the Retroperitoneum

Lee JB, Kim J, Oh YG, Lee CH, Son SK, Nam SL, Suh KS

  • KMID: 2083741
  • Korean J Gynecol Oncol Colposc.
  • 1999 Jun;10(2):194-199.
Cellular schwannoma is a variant of schwannoma, and is diagnosed as malignant tumor in over one fourth of cases because of its cellularity, mitotic activity and the occasional presence of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A case of Primary Serous Papillary Carcinoma of the Peritoneum.

Park MC, Shin JH, Lee JM, Kim YY, Park CY, Nam SI, Cho H

  • KMID: 2083740
  • Korean J Gynecol Oncol Colposc.
  • 1999 Jun;10(2):190-193.
Although the peritoneum is rare site for a primary neoplasm, certain malignant neoplasms may arise from it. A case of 63-year-old woman who had a serous papillary carcinoma of peritoneal...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
3 Cases of Synchronous Primary Carcinomas

Kim TJ, Lim KT, Jung HW, Lee KH, Shim JU, Chung YC, Kim DO, Lee HB, Park CT

  • KMID: 2083739
  • Korean J Gynecol Oncol Colposc.
  • 1999 Jun;10(2):183-189.
Three cases of synchronous carcinomas of endometrium-fallopian tube, endometrium-cervix and endometrium-ovary are reported. Case 1 is endometrial endometrioid adenocarcinoma with FIGO stageIb, Grade 2 and tubal serous adenocarcinoma with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Predictability of the Survival using Prognostic Index (PI) of Patients with Epithelial Ovarian Cancer

Cho SH, Kim SR, Moon H, Lee JA, Hwang YY, Moon YJ, Shin JS, Kim KT, Chung CY

  • KMID: 2083738
  • Korean J Gynecol Oncol Colposc.
  • 1999 Jun;10(2):173-182.
OBJECTIVES: To predict of the survival of patients with epithelial ovarian cancer, multivariable analysis was done to identify variables with independent prognostic factors. Based on materials from 191 clinical...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Neoadjuvant Chemotherapy for the Bulky-endophytic or Barrel-shaped Cervix

Lee JH, Cho SH, Kim SR, Cho SH, Moon H, Lee JA, Hwang YY, Ryu KY, Kim KT, Kong MS, Lee MH, Hwang JH

  • KMID: 2083737
  • Korean J Gynecol Oncol Colposc.
  • 1999 Jun;10(2):164-172.
OBJECTIVES: This retrospective study was conducted to analyze the hypothesis that with neoadjuvant chemotherapy of vinblastine, bleomycin, and cisplatin followed by radical hysterectomy or radiation therapy and concurrent chemoradiation...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Accuracy of Cervical Pap Smear

Cho SH, Kim SR, Moon H, Lee JA, Hwang YY, Kim KT, Goh SH

  • KMID: 2083736
  • Korean J Gynecol Oncol Colposc.
  • 1999 Jun;10(2):156-163.
BACKGROUND: Carcinoma of the uterine cervix is a theoretically preventable disease because its precursor lesions can be detected by cervical Papanicolau smears and appropriately treated, Although cervical cytology screening...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Phase III Study of Pirarubicin / Cyclophosphamide / CDDP(CTP) vs. Doxorubicin / Cyclophosphamide / CDDP(CAP) Combination Chemotherapy in Advanced Epithelial Ovarian Cancer

Kim YB, Kim JW, Park NH, Song YS, Kang SB, Lee HP, Roh JW, Lee CM, Lee TS

  • KMID: 2083735
  • Korean J Gynecol Oncol Colposc.
  • 1999 Jun;10(2):148-155.
Backgrouad & Aims: Cyclophosphamide, adriamycin and cisplatin(CAP) combination chemo- therapy improved the response rate in the treatment of advanced epithelial ovarian cancer, and it has been the gold standard. However,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Association Between Apoptosis and Development of the Cervical Neoplasia

Kim TJ, Kim JW, Kim HS, Chun YK, Paik DJ, Lim KT, Jung HW, Lee KH, Park IS, Park CT, Shim JU

  • KMID: 2083734
  • Korean J Gynecol Oncol Colposc.
  • 1999 Jun;10(2):138-147.
Apoptosis, including the programmed cell death, is important event in normal cell turnover and maintenance of adult tissues. Apoptosis exerts a homeostatic function in relation to tissues dynamics, as the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
HER-2/neu Oncogene Amplification; A Factor for Predicting Response of Platinum-based Combination Chemotherapy in Ovarian Cancers

Kim YB, Kim JW, Park NH, Song YS, Kang SB, Lee HP, Roh JW, Lee CM

  • KMID: 2083733
  • Korean J Gynecol Oncol Colposc.
  • 1999 Jun;10(2):130-137.
BACKGROUND: The HER-2/neu proto-oncogene (also known as c-ErbB-2) encodes a 185 kD transmembrane glycoprotein with intrinsic tyrosine kinase activity. Many studies revealed the correlation between the aberrant overexpression of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expression of p73 in Null-p53 SKOV3 Ovarian Cancer Cell Line

Whang JD, Park CS, Choi JJ, Kim JS, Bae DS, Lee JH

  • KMID: 2083732
  • Korean J Gynecol Oncol Colposc.
  • 1999 Jun;10(2):122-129.
p73, a first p53 relative, has been identified at chromosome 1p36, a region that is deleted in variety of human cancers. This protein shares strong homology with p53 protein, suggesting...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinico-Pathologic Study on Borderline Epithelial Tumors of the Ovary

Cho SH, Kim SR, Moon H, Lee JA, Hwang YY, Moon YJ, Han DI, Shin JS, Kim KT

  • KMID: 2083731
  • Korean J Gynecol Oncol Colposc.
  • 1999 Jun;10(2):115-121.
Twenty six cases of borderline ovarian tumor(BOT) were treated between Jan. 1985 and Dec. 1997 at the Department of Obstetrics and Gynecology, Hanyang University. The clinical records were reviewed for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr